Dr. Ronald E. Cape to Retire from EntreMed Board of...( ROCKVILLE Md. April 7 2008 /- Ent...),Health
Navigation Links
Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
Date:4/7/2008
ROCKVILLE, Md., April 7, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the retirement of Ronald E. Cape, Ph.D. as Director, effective June 5, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )
Dr. Cape has been a Director of EntreMed since 2003, and has been instrumental in helping the Company chart its path forward in multi-mechanism oncology drugs. Dr. Cape was the co-founder, Chairman and CEO of Cetus Corporation, a world leader and pioneer in genetic engineering, including the discovery and development of the polymerase chain reaction (PCR), for which Cetus scientist Kary Mullis received the Nobel Prize. Cetus later merged with Chiron Corporation. Dr. Cape was the founding chairman of Darwin Molecular Corporation, which was later sold to Chiroscience plc. He was also a founding member of the Biotechnology Industry Organization and served as its President for three years.
Dr. Cape is a fellow of the American Academy of Arts and Sciences, the
American Academy of Microbiology and the American Association for the
Advancement of Science. He is the recipient of many awards, including the
2007 Biotechnology Heritage Award, and has held dozens of prestigious board
positions in the public and private sectors. In recent years, Dr. Cape has
been an investor in the field of biotechnology and a board member of
various public and private companies. He has also served on the boards of
Princeton University, Rockefeller University, the Whitehead Institute at
MIT, and the Board of Rege
'/>"/>
| SOURCE EntreMed, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. International Soccer Superstar Ronaldinho Signs With Nutrilite(TM)
2. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
3. Philadelphia Ronald McDonald House(R) at Front & Erie Celebrates Grand Opening
4. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
5. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
6. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. East Ridge Retirement Village Announces Enhancement Plan
9. Increased Heart Risk Seen for Retired NFL Players
10. Mayo Clinic finds retired NFL players at increased risk for heart problems
11. AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits
Post Your Comments:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2[0] Cytiva's one45 Software Rebrands Healthcare Education Administration Products[0] Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events[0] New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation[0] Women's Alcohol Use Tied to Delayed Childbearing
...ntists have conducted a study, the first of its ki...he experiment was performed on mice, yet scientist.... The cause for Type 2 diabetes is still unknow... this. Yet one of the features of this disease is...
...archers at UT Southwestern Medical Center have fou...n inducing hypertension. "We have discovered that...f the risk of hypertension, it actually induces hy...asin, associate professor of internal medicine and...
...ious studies have shown that inflammation may some...alignant. UCSF scientists// have now discovered wh...cally, the "innate" immune system's Pac-Man-like w...and destroy invading microbes when receptors on th...
...archers at San Antonio's South Texas Center for Em...onio Health Science Center// (UTHSC) have come tog...hat will prevent Chlamydia. Chlamydia is a common...y the bacterium, Chlamydia trachomatis, which can ...
Other Medicine News:Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:C-Reactive Protein Induces Hypertension 2Health News:Inflammation can Lead to Cancer 2Health News:A Combined Research for Producing Chlamydia Vaccine Begins 2(Date:8/19/2008)...swire-FirstCall/ -- Vical Incorporated,(Nasdaq: V...h the Karolinska,Institutet (KI), a leading Europe...or Infectious Disease Control (SMI), a governmenta...adjuvant with the Biojector(R),2000 needle-free in...,OTCBB: BJCT) for a multivalent preventive DNA vac...
(Date:8/19/2008)... /- VION,PHARMACEUTICALS, I...d,entered into an agreement with the Dutch-Belgian...the "HOVON") to conduct a clinical trial of,laromu...emission-induction,therapy in patients aged 18-65 ...ia (AML) and high-risk myelodysplasia (MDS)., Ala...
(Date:8/18/2008).../PRNewswire-USNewswire/ -- Due to an,exceptionally...s in,southeastern Pennsylvania, the Department of ...ill be stepping up efforts this week to combat the...ely to carry -- the virus., While only one human ...s year (a 27-year-old Montgomery County woman), DE...
(Date:8/18/2008)...re-USNewswire/ -- Boston University and Aubrey,Mil... Human Genetics, Inc.,("CHG") and Director of the ...nounced that CHG will no longer offer testing serv...tics, Inc., These patented tests include tests re... or Connexin 26 mutations, developmental disorders...
Breaking Medicine Technology:Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 1Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 2Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 3Gene mutation improves leukemia drugs effect 22091 1Gene mutation improves leukemia drugs effect 22091 2People with lower incomes lower education levels have higher death rates 22089 1People with lower incomes lower education levels have higher death rates 22089 2Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 1Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 2[0] Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control[0] Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy[0] Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities[0] Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
..., 2007 /PRNewswire-FirstCall/ --,SuperGen Inc. ann...ons at the American Association for Cancer Researc...ese presentations,will focus on data concerning ma...ng its lead tyrosine kinase inhibitor compound,MP...target involved,in cancer cell drug resistance. Pr...
... 2007 -- CytImmune, a,clinical stage nanomedicine...ization of multifunctional, tumor-targeted therapi...at the 43rd American,Society of Clinical Oncology ...poster session will take place from 8:00 am to 12,...mmune will,present the poster abstract entitled "P...
Other Medicine Technology:SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 2SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 4CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
Quatroloc Revision Hip System
A stable revision design with extensive sizes
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |